MedTrace Logo

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

NCT02786758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-02-28

No results posted yet for this study

Summary

This study will offer proof of concept that scaling up treatment for Hepatitis C virus (HCV) in individuals co-infected with HIV could lead to elimination of HCV/HIV co-infection in gay and bisexual men by treating prevalent infection, thereby reducing new primary infections and re-infection.

Conditions

  • Hepatitis C
  • HIV

Sponsors & Collaborators

  • The Alfred

    collaborator OTHER

  • Macfarlane Burnet Institute for Medical Research and Public Health Ltd

    lead OTHER

Principal Investigators

  • Margaret Hellard · Burnet Institute

  • Joseph Doyle · The Alfred

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-07-31
Completion
2019-08-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786758 on ClinicalTrials.gov